WHO: Covid-19 vaccine maybe available in a year

BRUSSELS: According to the head of the World Health Organisation said, Covid-19 vaccine could take a year before one were to be invented. However, it is not certain that scientists will be able to create an effective vaccine against the coronavirus that has caused the COVID-19 pandemic.

Tedros Adhanom Ghebreyesus said that, “if such a vaccine became a reality, it should become a public good available to all. It would be very difficult to say for sure that we will have a vaccine. We never had a vaccine for a coronavirus. So this will be, when discovered, hoping that it will be discovered, it will be the first one.”

He further said that, “the WHO had already more than a 100 candidates for a vaccine of which one was at an advanced stage of development. Hoping that there will be a vaccine, the estimate is we may have a vaccine within one year. If accelerated, it could be even less than that, but by a couple of months. That’s what scientists are saying.”

  • Related Posts

    How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

    BMJ Research Forum all set to mull over in Delhi on September 5 New Delhi: Research in healthcare in India is a dime a dozen. But the real question that…

    Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

    Dr Rajendra Pratap Gupta gets nominated to advise UN Secretary General Geneva/ New Delhi: Former advisor to Union Health Minister of India JP Nadda in his earlier stint and a…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

    US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

    US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

    Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

    Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

    Puresta launches EVERQ, AI-powered skin-health platform

    Puresta launches EVERQ, AI-powered skin-health platform

    Stem cell therapy for autism only in approved clinical trials: Centre

    Stem cell therapy for autism only in approved clinical trials: Centre